Showing results (1171-1180 of 8,959) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|August 2, 2024
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trialFahong Li, Lihong Qu, Yanhong Liu, et al.Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.Journal of Hepatology|August 29, 2024
Association of food insecurity with MASLD prevalence and liver-related mortalityZobair M Younossi, Shira Zelber-Sagi, Carina Kuglemas, et al.Journal of Hepatology|September 1, 1991
Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic miceN Dubois, M Bennoun, I Allemand, et al.Journal of Hepatology|September 1, 1991
HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH)E Villa, I Ferretti, M De Palma, et al.Journal of Hepatology|April 26, 2006
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver diseaseSilvia Gaia, Antonina Smedile, Paola Omedè, et al.Journal of Hepatology|April 26, 2006
Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-MKhalid A Tazi, Jean-Jacques Quioc, Véronique Saada, et al.Journal of Hepatology|March 28, 2006
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasivenessSuzanne M de la Monte, Seishu Tamaki, M Chiara Cantarini, et al.Journal of Hepatology|March 7, 2006
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCAlaa Melhem, Nidal Muhanna, Amal Bishara, et al.Pageof 896